Sign in
4

Changes in Ownership

Syndax Pharmaceuticals Inc Filed Acc 0001562180-21-001044

Chief Executive Officer sold 35,156 shares at $20.55 ($722,403)

  • Chief Executive Officer acquired 35,156 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Morrison Briggs · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-02-08 Exercise or conversion : show line 1 in the form +35,156 $7.20 $253,123 83,492 D
2021-02-08 Sale : show line 2 in the form −35,156 $20.55 $722,403 48,336 D
Open-market sales · 35,156 sh · avg $20.55 · $722,403

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-02-08 Exercise or conversion : show line 3 in the form Stock Options (Right to buy) −35,156 0 D
Loading xslF345X03/primarydocument.xml…